Medical Companion
Your medical letter.
Made clearer.
A hospital letter can be a lot to take in. Receive a detailed, personalized companion that works through your document in clear, everyday language — with space to explain the wording, explore the detail and prepare your questions.
$40 for your letter’s full explanationOne-off payment
We explain the document’s wording. Your healthcare professional remains the person to ask about your care.
A little less jargon.A little more clarity.
2–10 pages, usually
Clear explanations, section by section.
Terms, dates and questions to revisit.
What you actually receive
A detailed explanation.
Space to understand.
Your personalized companion usually runs to 2–10 pages, depending on your document’s length and complexity.
It begins with the main points, then works through the detail in manageable sections. Explore the illustrated example below: a complex letter explained through pictures, short illustrated sections and extra detail you can open when you need it.
The structure and length follow the letter you send. The sections shown here illustrate the kind of depth a companion can include.
Read the illustrated eight-page exampleYour letter at a glance
A clear opening overview, so you can orient yourself before reading further.
The detail, explained step by step
A fuller explanation of the relevant sections and how the wording fits together.
Words and phrases unpacked
Medical terms and abbreviations explained in the context of your letter.
Dates, instructions and next steps
The practical details already stated in the document, organized for easy reference.
Questions for your care team
Thoughtful, neutral prompts to help you prepare for your next conversation.
What still needs clarification
Uncertainties or missing information to discuss with the person who sent the letter.
Open an illustrated example
A complex medical letter.
Clearly explained.
Explore an eight-page illustrated explanation of a complex cardiology letter. Clear language, useful diagrams and a practical overview of the results and next steps. More detail is available within each section.
The original documentRead the clinical letter
Original clinical letter · 1 of 2
Fictional cardiology review letter
Original source | 1 of 2 | Created only for this demonstration
Example Cardiology Service
Date: September 15, 2026
To: Alex Morgan's primary care clinician
Re: Alex Morgan, aged 68 | Copy to: patient
1. Diagnoses and reason for review
Thank you for your ongoing care of Alex, reviewed following admission from September 4-8 with decompensated heart failure. The working diagnoses are heart failure with reduced left ventricular ejection fraction (HFrEF; LVEF 35-40%), persistent atrial fibrillation, hypertension, established CKD G3a and iron deficiency with mild anemia. The etiology of the ventricular dysfunction remains under investigation.
2. Interval history and examination
Following diuresis, orthopnea and peripheral edema have improved. Exertional dyspnea and fatigue persist after approximately 220 yards (200 meters) or one flight of stairs; functional limitation is currently NYHA II-III. Alex denies chest pain, syncope and overt bleeding. Weight is 190 lb (86.2 kg), BP 112/70 mmHg, pulse 84 bpm irregular and oxygen saturation 97% on room air. There is mild bilateral ankle edema without respiratory distress. Alex is clinically compensated at today's review.
3. Cardiac investigations
Transthoracic echocardiography demonstrates a mildly dilated left ventricle with global systolic impairment and estimated LVEF 35-40%, left atrial enlargement and mild functional mitral regurgitation. Right ventricular systolic function is preserved. There is no significant aortic stenosis or pericardial effusion. ECG shows atrial fibrillation with a ventricular rate of 84 bpm, QRS 98 ms and no acute ischemic changes. Chest radiograph shows reduced pulmonary vascular congestion compared with admission, without focal consolidation.
4. Blood results and renal history
Lab results dated September 14: creatinine 1.39 mg/dL; eGFR 52 mL/min/1.73 m2; sodium 138 mEq/L; potassium 4.6 mEq/L; hemoglobin 11.8 g/dL; ferritin 26 ng/mL; transferrin saturation 16%; NT-proBNP 1420 pg/mL. The eGFR has ranged from 48 to 56 over the preceding six months, supporting established CKD G3a. Albuminuria category is not yet available; urine ACR is requested. The iron results are consistent with iron deficiency. The cause of the anemia is not established.
Original clinical letter · 2 of 2
Assessment, treatment and follow-up
Original source | 2 of 2 | Continuation of the fictional letter
5. Assessment and medication review
The ventricular dysfunction may be multifactorial; hypertension-related cardiomyopathy and an arrhythmia-related contribution are possible. Neither mechanism is confirmed. Cardiac MRI is requested to assess ventricular function and tissue characteristics and help clarify etiology. No MRI result is available. AFib remains persistent, although the resting ventricular rate is controlled at this visit. No cardioversion or device implantation is currently scheduled.
The reconciled medication list is bisoprolol, ramipril, eplerenone, dapagliflozin, furosemide and apixaban, all to continue at the doses on the current prescription. There is no dose change today. Dapagliflozin is prescribed for heart failure, not a diagnosis of diabetes. Apixaban is prescribed for AFib-related stroke prevention. Exact doses are deliberately omitted from this public fictional example; it must not be used as a dosing guide.
6. Actions requested
- primary care office: arrange repeat basic metabolic panel, creatinine/eGFR, CBC and urine ACR by September 22; review these results and communicate concerns to the heart failure team. Alex should contact the practice if testing has not been arranged.
- primary care office: review the unexplained iron deficiency/anemia within two weeks of this letter and arrange appropriate investigation. The heart failure team will discuss whether iron replacement is indicated; no product, route or dose is prescribed here.
- Heart failure nurse: telephone review scheduled for September 29 at 10:00 AM to assess symptoms, blood pressure and repeat lab results. Any subsequent medication titration will be clinician-led.
- Cardiac MRI: requested, with an intended window of four to six weeks; no appointment is confirmed. Repeat echocardiography is planned after approximately three months of optimized treatment; no scan date is scheduled.
- Cardiology follow-up: scheduled for November 24 at 11:00 AM. A cardiac rehabilitation assessment referral has also been made; the rehabilitation team will contact Alex. The letter does not provide an exercise prescription.
7. Safety-net instructions given in this fictional case
Call 911 for severe breathing difficulty, chest pain that does not settle, sudden signs of stroke, collapse with abnormal responsiveness, or bleeding that cannot be stopped. Seek same-day advice from the heart failure team or primary care clinician for increasing breathlessness or ankle swelling, new dizziness, or weight gain of more than 4.4 lb (2 kg) over three days. If the care team cannot be reached, seek same-day care at an urgent care clinic. Call 911 for emergency symptoms. Alex has been asked to record morning weight and bring the record to review. No self-adjustment of medication doses is authorized. Do not stop apixaban without clinical advice.
Dr Rowan Ellis
Fictional Cardiologist
End of invented source letter. No affiliation with a real medical practice is implied.
OVERVIEW
The main points in your letter
Your cardiology letter describes your progress since leaving the hospital, your test results and your treatment plan. This explanation sets out what the findings mean and what happens next.
Your heart function
Your heart is pumping less strongly than it should.
Your progress
Treatment has reduced the fluid buildup. You are still experiencing tiredness and shortness of breath.
More about this part of the letter
This letter brings several subjects together: heart pumping function, an irregular heartbeat, kidney monitoring, low iron and the practical plan after a hospital stay. The following pages work through each subject and keep the team's findings distinct from questions that are still open.
What has been established in the letter
- Reduced pumping function: the heart ultrasound estimates the left ventricular ejection fraction at 35-40%. The clinician calls this HFrEF. Page 2 explains those words and what the percentage describes.
- Atrial fibrillation: the heartbeat remains irregular. At this visit the measured resting rate is 84 beats per minute. Rate, rhythm and protection against clots are related but separate matters; page 3 explains the distinction.
- Other findings need attention: the letter records established CKD G3a and iron deficiency with mild anemia. Kidney results are being monitored; the cause of the anemia still needs investigation.
What has changed, and what has not
Compared with admission, the letter describes less fluid congestion and improved symptoms when lying down. It also records ongoing limits with walking and stairs. Those statements can both be true. Improvement since your hospital stay does not mean that every symptom has resolved or that the underlying condition has disappeared.
There is no medication dose change at this review. The letter lists the medications to continue according to the current prescription. Future changes may be considered after the repeat tests and nurse review; they are not instructions to change anything today.
The first practical milestones
By September 22: repeat blood and urine tests are requested through the primary care office. September 29, 10:00 AM: a nurse telephone review is scheduled. An MRI is requested but not yet scheduled; cardiology follow-up is scheduled for November 24 at 11:00 AM.
This sample is not a personal treatment plan.1 / 8
HEART FUNCTION
What your heart scan shows
Your heart scan shows a weaker squeeze in the left ventricle, the main chamber that pumps blood to the rest of your body.
Your 35-40% result
This is the share of blood leaving your left ventricle with each beat. Your result is below the expected range. It does not measure your whole heart's function.
Other findings on your scan
One heart valve allows a small amount of blood to leak backward. Your letter describes this as mild and does not recommend valve surgery.
More about this part of the letter
The main pumping chamber
The left ventricle is the chamber that pumps blood out to the body. In this letter, it is described as mildly enlarged and its squeeze is weaker than expected. Global systolic impairment means the reduced squeezing function is described across the chamber rather than confined to one small area. These are descriptions of the scan, not a complete explanation of why the change happened.
The other ultrasound findings
Left atrial enlargement: the chamber above the left ventricle is larger than expected. Mild functional mitral regurgitation: a small amount of blood leaks backwards through the mitral valve when the heart squeezes; “functional” describes leakage related to how the heart and valve apparatus are working together. The report calls it mild. It does not recommend valve surgery.
Preserved right ventricular function means the right-sided pumping function is described as maintained. No significant aortic stenosis means the report does not describe important narrowing of that valve. No pericardial effusion means it does not report fluid collected in the sac around the heart. These findings relate to specific parts of the examination; they do not cancel the reduced left ventricular function.
Symptoms, improvement and the cause
The clinician uses NYHA II-III to describe the current level of limitation from symptoms with activity. In your letter, the practical examples are walking about 220 yards (200 meters) or climbing one flight of stairs. It is a description of symptoms and activity at this stage, rather than a timetable for the future.
The letter says the cause may involve long-standing high blood pressure and an irregular or previously fast rhythm. The words “possible” and “not confirmed” matter. The MRI is intended to help clarify the picture. The explanation cannot turn those possibilities into a confirmed cause.
General background: AHA: Heart failure · AHA: Ejection fraction
This sample is not a personal treatment plan.2 / 8
ATRIAL FIBRILLATION (AFib)
Understanding your heart rhythm
Your letter records atrial fibrillation, often called AFib: an irregular heart rhythm that is still present. Heart rate and heart rhythm describe different aspects of your heartbeat.
Your heart rate at the visit
Your pulse was 84 beats per minute. Its rate was controlled at the visit, although the rhythm remained irregular.
Your protection against clots
AFib can increase your risk of blood clots and stroke. Apixaban helps reduce that risk. Controlling your heart rate does not replace this protection.
More about this part of the letter
Rate and rhythm are different
Atrial fibrillation (AFib) is an irregular heart rhythm. “Persistent” here means it is still present. The ECG records a resting rate of 84 beats per minute. The clinician describes the rate as controlled at this visit, while also stating that the rhythm remains AFib. A controlled rate is not the same as a return to a regular rhythm.
The letter also names apixaban for AFib-related stroke prevention. A medication used to reduce clot risk has a different purpose from a medication used to control the heart rate. The record does not say that controlling the pulse removes the reason for the anticoagulant. No cardioversion procedure is scheduled; there is no date to prepare for in this letter.
What the ECG can and cannot settle
An ECG is a recording of electrical activity in the heart. The QRS measurement, 98 milliseconds, concerns part of that electrical recording. It is not the same measurement as the ejection fraction on the ultrasound. The statement that there are no acute ischemic changes describes this ECG; it is not a guarantee that every possible coronary problem has been excluded.
Why the breathing description sounds mixed
Orthopnoea is breathlessness when lying flat; edema is swelling associated with fluid in the tissues. The letter says both have improved following diuresis, meaning treatment that increased fluid loss through urine. The chest X-ray also shows less congestion than on admission. This comparison tells us the situation has improved relative to the earlier image.
You still become breathless with exertion and has mild ankle swelling. The letter records both the improvement and the remaining symptoms. “No focal consolidation” means the X-ray does not describe a localized area of dense change of that type. It should not be rewritten as “the lungs are completely normal”.
A snapshot from the appointment
The blood pressure is recorded as 112/70, oxygen saturation as 97% while breathing room air, and weight as 190 lb (86.2 kg). “Clinically compensated” describes the clinician's assessment at the review: the condition is sufficiently balanced for the stated follow-up plan. It does not mean cured, free of symptoms or unable to worsen later.
General background: AHA: Atrial fibrillation · AHA: Heart failure
This sample is not a personal treatment plan.3 / 8
BLOOD AND URINE TESTS
Your kidney function and iron
Your letter also reports reduced kidney function and low iron. Both need follow-up alongside your heart treatment.
Your kidney function
Your eGFR is 52 mL/min/1.73 m². This estimates filtering, not a percentage. Similar results over six months support chronic kidney disease, stage 3a. A urine test is still needed.
Your iron and hemoglobin
You have low iron and mild anemia. Anemia means your blood has less of its oxygen-carrying protein than expected. This can contribute to tiredness.
More about this part of the letter
Several measurements sit together in the results paragraph, but they answer different questions. This table repeats the fictional figures and explains their role. It does not independently grade each result or provide a treatment target.
| Result in the letter | What it helps describe |
|---|---|
| Creatinine 1.39 mg/dL eGFR 52 mL/min/1.73 m2 | Kidney filtration. The eGFR is an estimate calculated from a blood test and other information. |
| Sodium 138 mEq/L Potassium 4.6 mEq/L | Blood salts that the team monitors alongside kidney function and medications. |
| Hemoglobin 11.8 g/dL | The oxygen-carrying protein in red blood cells. The clinician describes mild anemia. |
| Ferritin 26 ng/mL Transferrin saturation 16% | Measures related to iron stores and availability. The clinician identifies iron deficiency. |
| NT-proBNP 1420 pg/mL | A marker used in the assessment of heart failure. The letter does not use it to predict your future. |
| Urine ACR: requested, no result | A urine measure of albumin compared with creatinine; it adds another part of the kidney picture. |
Why the previous kidney results matter
The letter gives eGFR values of 48-56 over six months and explicitly records established CKD G3a. G3a is a category of reduced kidney filtration. The diagnosis in this example is based on a history of results, not one isolated reading. The urine albumin category is still unknown, so it would be inaccurate to invent a complete kidney classification.
Iron deficiency and anemia need an explanation too
The clinician has identified low iron alongside mild anemia. Anemia can be associated with tiredness or breathlessness, but the letter does not say how much of your symptoms it explains. It does not identify the cause of the iron deficiency. That is why the primary care clinician is asked to review it and arrange appropriate investigation.
No iron product, route or dose is prescribed in the letter. The heart failure team will discuss whether replacement is indicated. A possible future treatment should not be rewritten as an instruction to buy or start a supplement.
General background: NIDDK: Kidney tests · NHLBI: Iron-deficiency anemia
This sample is not a personal treatment plan.4 / 8
MEDICINES IN THE LETTER
Your medications explained
Your letter lists six medications. This page explains their purposes. Take them at the doses and times on your current prescription.
Bisoprolol
Slows your heart rate and reduces its workload.
Ramipril
Relaxes blood vessels so your heart can pump more easily.
Eplerenone
Blocks a hormone that can worsen heart failure.
Dapagliflozin
Treats your heart failure, even if you do not have diabetes.
Furosemide
Helps your body remove excess fluid through urine.
Apixaban
Helps prevent clots and reduce your risk of an AFib-related stroke.
More about this part of the letter
The names can look like one long list. They belong to different medication groups and may have overlapping purposes. The explanations below give general background to the names in this letter; they do not confirm that a medication or dose is suitable for a particular reader.
| Medication in this letter | Plain-English background |
|---|---|
| Bisoprolol | A beta blocker. It slows the heart rate and is used in heart failure and some other heart conditions. A slower measured pulse does not prove that AFib has ended. |
| Ramipril | An ACE inhibitor. It widens blood vessels, making it easier for the heart to pump. Kidney function and potassium are monitored during treatment and dose changes. |
| Eplerenone | A medication that blocks the hormone aldosterone. It is used in heart failure; the team monitors potassium and kidney function. It is not interchangeable with every other “water tablet”. |
| Dapagliflozin | An SGLT2 inhibitor used for several conditions, including heart failure. The letter specifically says it is prescribed here for heart failure, not because you have been diagnosed with diabetes. |
| Furosemide | A diuretic, sometimes called a water tablet. It helps remove excess fluid through urine. The source gives no permission to take extra tablets in response to a weight change. |
| Apixaban | An anticoagulant that reduces the formation of blood clots. The stated purpose here is AFib-related stroke prevention. It does not itself restore a regular heartbeat. |
What “reconciled” and “titration” mean
Reconciled means the medication list has been checked as part of the review. Titration means adjusting treatment step by step under clinical supervision. The nurse will review symptoms, blood pressure and new results before any subsequent clinician-led change. This is a future review, not an instruction to increase or decrease doses now.
Information this letter does not supply
The public example is not a complete prescription, missed-dose guide or list of side effects and interactions. It gives no personalized sick-day plan. Those questions belong with the prescriber or pharmacist. Your letter specifically says not to stop apixaban without clinical advice; the urgent warnings are preserved on page 7.
General background: AHA: Heart failure medications · AHA: AFib medications
This sample is not a personal treatment plan.5 / 8
THE FOLLOW-UP PLAN
Your tests and follow-up
Your letter confirms two appointments and requests more tests. These dates are from the September 15, 2026 sample.
Tests requested
Your primary care office will arrange and review blood and urine tests, then update your heart team.
Review requested
Your primary care clinician is asked to investigate your low iron and anemia.
Phone visit confirmed
Your heart failure nurse will review your symptoms and test results.
Office visit confirmed
You have a follow-up appointment with your cardiology team.
Awaiting scheduling: heart MRI (about 4-6 weeks), repeat heart ultrasound (about three months after treatment is optimized), and a cardiac rehabilitation assessment.
More about this part of the letter
A request for a test and a confirmed appointment are different. This timeline keeps the responsible service, intended timing and booking status separate. All dates come from the fictional letter dated September 15, 2026.
| When | Who and what the letter says |
|---|---|
| By September 22 | primary care office: arrange repeat basic metabolic panel, creatinine/eGFR, complete blood count and urine ACR. The practice is asked to review the results and share concerns with the heart failure team. You should contact the practice if testing has not been arranged. |
| Within two weeks By September 29 | primary care office: review the unexplained iron deficiency/anemia and arrange appropriate investigation. “Within two weeks” is the letter's timeframe; September 29 is the corresponding date from September 15. No specific appointment time is supplied. |
| September 29 10:00 | Heart failure nurse: telephone review is scheduled. The stated subjects are symptoms, blood pressure and repeat test results, with any later medication changes to be clinician-led. |
| Intended in 4-6 weeks Around October 13-27 | Cardiac MRI has been requested. This date range translates the intended window; it is not a confirmed appointment. No MRI findings exist yet in the letter. |
| November 24 11:00 | Cardiology follow-up is scheduled. This is a confirmed review in the source, unlike the pending scan appointments. |
| Approximately 3 months after optimized treatment | Repeat echocardiogram is planned. The letter does not fix the date or precisely define the start of that treatment period. It would be misleading to invent a December booking. |
| Date not supplied | A cardiac rehabilitation assessment referral has been made. The rehabilitation team will contact you. The letter gives no personalized exercise program. |
Who is expected to review the results?
The primary care office is asked to review the repeat tests and communicate concerns to the heart failure team. The nurse review will also consider the new results. The letter does not promise that every result will be available by the call or say how you will receive each result. Those are useful administrative details to clarify.
What to have in view for the review
The fictional letter asks you to record morning weight and bring the record to review. A current prescription list and the questions on page 8 could also help a conversation, but those are preparation prompts from this explanation, not new treatment instructions. The MRI result should not be assumed to exist until the scan has taken place and been reported.
This sample is not a personal treatment plan.6 / 8
SYMPTOMS AND URGENT ADVICE
When to seek medical help
Your letter explains which symptoms need emergency care and when to contact your care team the same day.
Call 911 now
Severe difficulty breathing; chest pain that does not settle; sudden stroke symptoms; collapse with an unusual or absent response; or bleeding that cannot be stopped.
Contact your care team today
Report worsening shortness of breath or ankle swelling, new dizziness, or weight gain of more than 4.4 lb (2 kg) in three days. If your team is unavailable, seek same-day care at an urgent care clinic.
Stroke signs include face drooping, arm weakness or trouble speaking. Call 911 even if symptoms go away.
More about this part of the letter
A clearer explanation must preserve the strength of the original warnings. The following instructions belong to the fictional source letter. They show how urgent information can remain easy to find in a longer companion.
The letter asks you to record morning weight. It gives no permission to self-adjust medication doses and specifically says not to stop apixaban without clinical advice. An instruction to seek help is different from permission to take extra medication. A public sample cannot be used to decide what medication change a real person needs.
The unanswered parts of this particular letter
- The cause of reduced pumping function: high blood pressure and an arrhythmia-related contribution are possibilities. The MRI is requested to help clarify the cause, not to confirm an already established explanation.
- Recovery and long-term outlook: the letter does not predict a future ejection fraction, a timescale for recovery or a future need for a device.
- The cause of iron deficiency: this has not been established. The explanation cannot attribute it to diet, bleeding, medication or another condition without information from the clinical investigation.
- The complete kidney picture: urine ACR has not been reported. It cannot be supplied by inference from the eGFR.
- Further treatment and appointments: no iron regimen, cardioversion date, MRI appointment or repeat echo date is confirmed. No personalized exercise prescription is included.
What reassuring phrases actually cover
“Improved”, “controlled at this visit” and “preserved” each describe something specific: a change since admission, the measured resting rate, or one part of heart function. They should not be stretched into “nothing is wrong” or “no further follow-up is needed”. Keeping the limits of each phrase is part of keeping the meaning intact.
General background: AHA: Emergency symptoms
This sample is not a personal treatment plan.7 / 8
PREPARING FOR YOUR REVIEW
Questions for your care team
Your letter leaves some questions open. You may want to discuss the cause of your reduced heart function and how your next tests will guide your care.
- What might have weakened my heart, and what could the MRI tell us?
- Who will explain my new test results and check why my iron is low?
- What should I do if a test or appointment is not arranged?
More about this part of the letter
You can choose the questions most relevant to your next appointment. These prompts connect directly to the gaps and plans in the letter. They support a conversation with the care team; they do not suggest that a particular answer or treatment is correct.
The heart findings and the pending scan
- What are you hoping the cardiac MRI will clarify about the cause of the reduced pumping function?
- When you say “optimized treatment”, what does that mean in my case, and when will the repeat echo be arranged?
- Is the current plan for AFib focused on rate control, rhythm treatment, or both? When will that be reviewed?
Tests, medications and the handover
- Have the blood and urine tests for September 22 been arranged, and how will I receive the results?
- Who will investigate the iron deficiency, and what is the next step in finding its cause?
- Can we check my actual doses against my current prescription and discuss what to do if I miss a dose or become unwell?
- Which service should I contact if the MRI appointment does not arrive within the intended window?
Day-to-day questions to discuss
- What changes in my symptoms or weight should prompt a call under my own plan, and which number should I use?
- What activities are suitable while I wait for the rehabilitation assessment?
- Are there individual fluid, salt or medication instructions I need in writing? The letter does not give a personalized plan for these.
A few words to recognize next time
HFrEF: heart failure with reduced ejection fraction. AFib: atrial fibrillation. CKD: chronic kidney disease. basic metabolic panel: urea and electrolytes, a group of blood tests. CBC: complete blood count. ACR: albumin-to-creatinine ratio in urine. Timing words also matter: a test described as requested is not automatically scheduled.
About the background references: page-specific links point to American Heart Association and National Institutes of Health information used to check general terminology. These organizations have not reviewed or endorsed this sample. The invented source letter supplies the case facts; no real medical record was used. General sources were checked on September 15, 2026.
General background: AHA: Heart failure · AHA: Atrial fibrillation · NIDDK: Kidney tests · NHLBI: Iron-deficiency anemia
This sample is not a personal treatment plan.8 / 8
Your own companion normally runs to 2–10 pages, shaped around your document. This example uses pictures, short sections and optional extra detail to show how a complex letter can become easier to follow. Spoken reading depends on your browser.
Start with the letter you have
Which kind of document
is in front of you?
You do not need to know the right medical term. These are some of the documents we can help you read.
GP & hospital letters
Appointments, referrals, consultant letters and follow-up updates.
Explain my letter 02Written results & reports
The wording in blood test letters, scan reports and other written results.
Explain my report 03Care plans & summaries
Discharge summaries, treatment plans, surgery letters and medication reviews.
Explain my documentSomething different? Ask whether your document is suitable.
- 1
Send the letter you want explained
Use your existing letter or report. Include the relevant pages and cover personal details that are not needed.
- 2
Tell us what feels unclear
Choose the style of wording that helps you. You can also request audio where available.
- 3
Receive your full personal companion
Usually 2–10 pages of detailed explanation, organized into clear sections you can read, revisit and discuss.

For you. Or someone you care about.
Take it in
at your own pace.
Read it again before an appointment. Talk it through with a partner. Help a parent find the question they wanted to ask.
Your explanation gives you a clearer starting point for those conversations.
Helping with someone else’s letter? Make sure you have their permission or the authority to share it.
A few things you might wonder
Before you
send your letter.
Still unsure? You can ask a question before ordering.
Talk to Clarity CompanionHow long and detailed is the explanation?
Your personalized companion is normally 2–10 pages long. It works through the relevant detail of your document in clear, manageable sections. The final length depends on the letter’s length and complexity, so the range is a guide rather than a fixed page count.
What will my explanation include?
A clear opening overview leads into a fuller explanation of the relevant sections, unfamiliar words and phrases, and the dates and instructions stated in your letter. Your companion can also include neutral questions for your care team and points that still need clarification. The content is shaped around the document you provide.
Can you explain scan or test-result letters?
We can explain the medical terms and wording in a written report. We do not assess the result independently, diagnose a condition or advise what treatment to choose. Your clinician is the right person to explain what the findings mean for your care.
How much does it cost?
A medical-letter explanation costs $40 per letter. It is a one-off payment. Check the order details before submitting, including any limits and audio availability.
Can I listen to my explanation?
Optional audio is available for some orders. Request it when ordering and check availability for your document. The illustrated fictional sample on this page lets you listen to each illustrated page when your browser supports spoken reading. You can also open extra written detail on each page. Your own personalized companion follows the document you provide.
Can I send a letter for someone else?
Yes, if you have their permission or the authority to share it. Include only what is needed to explain the letter, and cover unnecessary personal details before uploading.
What should I know about privacy?
Remove personal information that is not needed. The privacy notice explains document handling, AI-assisted processing, retention and your choices. Read the privacy policy before uploading.
What if I need an answer urgently?
This is not an emergency service. If your concern is urgent or a deadline is close, contact your healthcare team or the organisation that sent the letter. Do not wait for this service to make a time-sensitive care decision.
Your full personal companion
Detailed explanations.
Clear, everyday language.
Usually 2–10 pages, thoughtfully organized around your medical letter and its detail.
$40your letter’s full explanation · one-off payment
Get my detailed explanation How your documents are handled